| Name | Title | Contact Details |
|---|
Dimond Hospitality Consulting Group Inc. is a Nashville, TN-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
Helen Keller Hospital is a not-for-proft, community hospital in Sheffield, AL. An acute care facility, Helen Keller Hospital is licensed to operate 185 beds. History Colbert County and the City of Sheffield opened a Hospital, March 22, 1921. At the time, this was called Colbert County Hospital. It is now known as Helen Keller Memorial Hospital, part of the Colbert County Healthcare Authority. Other healthcare entities under the umbrella the Colbert County Healthcare Authority include Red Bay Hospital, North Alabama Sleep Disorders Center and Northwest Practice Management. On May 21, 1979, the name of the hospital was changed to Helen Keller Hospital in honor of that great lady and world-renowned humanitarian. The continued growth of the Northwest Alabama Healthcare Authority is a result of the dedication of the Board of Trustees, the citizens of Colbert County and the hospital employees, who deliver excellent patient care. Helen Keller Hospital is fully accredited by the Joint Commission on Accreditation of Hospitals assuring the finest in medical care by the process of review inspection and updating. The Authority is governed by a nine-member Board of Trustees from Colbert County appointed by the County Commission serving in staggered six-year terms. While the Board of Trustees is ultimately responsible for the operation of the Authority, the details are delegated to the Authority President.
Country Doctor Community Health Centers is a non-profit 501(c)3 organization that maintains two clinic sites, Carolyn Downs Family Medical Center and Country Doctor Community Clinic. Since our founding, our primary goal has been to provide the highest
Somnia Inc is one of the leading providers in Healthcare, Pharmaceuticals, & Biotech. It is based in New Rochelle, NY. To find more information about Somnia Inc, please visit www.somniainc.com
Ascendis Pharma is focused on creating drug candidates that are improved versions of existing drugs, yielding more effective, lower-risk drugs with new patent life. Our proprietary TransCon platform is the leading, most versatile transient conjugation technology and is utilized to create clinically superior prodrugs in therapeutic areas characterized by high unmet medical need. TransCon technology creates novel long acting prodrugs of proteins, peptides and small molecules, suitable for either local or systemic treatment. Ascendis Pharma has a diversified and balanced high-value pipeline, including internal programs and partnerships together with market leaders on their key projects.